Pioglitazone, a PPARγ agonist, reduces nicotine craving in humans, with marginal effects on abuse potential

Possibly through their actions upon glia, peroxisome proliferator-activated receptor agonists (PPAR) have been shown to alter the abuse potential of addictive drugs in several preclinical models. The current study extends this research into the human laboratory as the first clinical study into the e...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pharmacol Biochem Behav
Asıl Yazarlar: Jones, Jermaine D., Comer, Sandra D., Metz, Verena E., Manubay, Jeanne M., Mogali, Shanthi, Ciccocioppo, Roberto, Martinez, Suky, Mumtaz, Mudassir, Bisaga, Adam
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5959043/
https://ncbi.nlm.nih.gov/pubmed/29020601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pbb.2017.10.002
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller